Tazarotene: The first receptor-selective topical retinoid for the treatment of psoriasisCHANDRARATNA, R. A. S.Journal of the American Academy of Dermatology. 1997, Vol 37, Num 2, pp S12-S17, issn 0190-9622, 3Conference Paper

Future trends : A new generation of retinoids. DiscussionCHANDRARATNA, R. A. S.Journal of the American Academy of Dermatology. 1998, Vol 39, Num 4, pp S149-S152, issn 0190-9622, 2Conference Paper

12-s-cis conformationally locked retinoids: thermal and photochemical interconversions leading to new geometric isomersCHANDRARATNA, R. A. S; OKAMURA, W. H.Tetrahedron letters. 1984, Vol 25, Num 10, pp 1003-1006, issn 0040-4039Article

Novel approaches for the treatment of psoriasisDISEPIO, D; CHANDRARATNA, R. A. S; NAGPAL, S et al.Drug discovery today. 1999, Vol 4, Num 5, pp 222-231, issn 1359-6446Article

A short and efficient synthesis of 4-[2,2-dimethyl-4(tol-4-yl)benzochrom-3-en-7-yl]benzoic acid : A potent retinoic acid receptor antagonistVULIGONDA, V; CHANDRARATNA, R. A. S.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 16, pp 2289-2290, issn 0960-894XArticle

Rational design of receptor-selective retinoids. DiscussionCHANDRARATNA, R. A. S; MARKS; MORAHAN et al.Journal of the American Academy of Dermatology. 1998, Vol 39, Num 4, pp S124-S128, issn 0190-9622, 2Conference Paper

Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligandsVULIGONDA, V; GARST, M. E; CHANDRARATNA, R. A. S et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 4, pp 589-594, issn 0960-894XArticle

Lack of involvement of retinoic acid receptor α in retinoid-induced skin irritation in hairless miceSTANDEVEN, A. M; TENG, M; CHANDRARATNA, R. A. S et al.Toxicology letters. 1997, Vol 92, Num 3, pp 231-240, issn 0378-4274Article

Electronic spectra of 12-c-cis conformationally locked retinalsCHANDRARATNA, R. A. S; BIRGE, R. R; OKAMURA, W. H et al.Tetrahedron letters. 1984, Vol 25, Num 10, pp 1007-1010, issn 0040-4039Article

Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cellsHAMMOND, L. A; VAN KRINKS, C. H; DURHAM, J et al.British journal of cancer. 2001, Vol 85, Num 3, pp 453-462, issn 0007-0920Article

Retinoic acid receptor α expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor statusFITZGERALD, P; TENG, M; CHANDRARATNA, R. A. S et al.Cancer research (Baltimore). 1997, Vol 57, Num 13, pp 2642-2650, issn 0008-5472Article

Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoidsAGARWAL, C; CHANDRARATNA, R. A. S; MIN TENG et al.Cell growth and differentiation. 1996, Vol 7, Num 4, pp 521-530, issn 1044-9523Article

Identification of a retinoic acid receptor α subtype specific agonistTENG, M; DUONG, T. T; KLEIN, E. S et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 16, pp 3035-3038, issn 0022-2623Article

Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid : Insight into the mechanism of retinoid action in psoriasisNAGPAL, S; THACHER, S. M; CHANDRARATNA, R. A. S et al.Cell growth and differentiation. 1996, Vol 7, Num 12, pp 1783-1791, issn 1044-9523Article

Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109 : Divergent effects from agonist at retinoic acid receptor γ in human keratinocytesTHACHER, S. M; NAGPAL, S; KLEIN, E. S et al.Cell growth and differentiation. 1999, Vol 10, Num 4, pp 255-262, issn 1044-9523Article

A new class of potent rar antagonists : Dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoidsVULIGONDA, V; STANDEVEN, A. M; ESCOBAR, M et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 5, pp 743-748, issn 0960-894XArticle

High affinity retinoic acid receptor antagonists : Analogs of AGN 193109JOHNSON, A. T; LIMING WANG; GILLETT, S. J et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 4, pp 573-576, issn 0960-894XArticle

Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cellsZHU, W.-Y; JONES, C. S; AMIN, S et al.Cancer research (Baltimore). 1999, Vol 59, Num 1, pp 85-90, issn 0008-5472Article

Tazarotene gel is safe and effective in the treatment of acne vulgaris : A multicenter, double-blind, vehicle-controlled studySHALITA, A. R; CHALKER, D. K; LEW-KAYA, D. A et al.Cutis (New York, NY). 1999, Vol 63, Num 6, pp 349-354, issn 0011-4162Article

Synthesis and biological activity of 1,2,3,4-tetrahydroquinoline and 3,4-(1H)-dihydroquinolin-2-one analogs of retinoic acidBEARD, R. L; TENG, M; COLON, D. F et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 18, pp 2373-2378, issn 0960-894XArticle

Molecular mechanisms of tazarotene action in psoriasisDUVIC, M; NAGPAL, S; ASANO, A. T et al.Journal of the American Academy of Dermatology. 1997, Vol 37, Num 2, pp S18-S24, issn 0190-9622, 3Conference Paper

Effects of structural changes on retinoid cytotoxicity in the CHO clonal assayODA, R. M; SHIMIZU, R. W; SABATINE, S. C et al.In vitro toxicology. 1996, Vol 9, Num 2, pp 173-181, issn 0888-319XArticle

Retinoic acid receptor antagonism in vivo expands the numbers of precursor cells during granulopoiesisWALKLEY, C. R; YUAN, Y-D; CHANDRARATNA, R. A. S et al.Leukemia. 2002, Vol 16, Num 9, pp 1763-1772, issn 0887-6924Article

Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancerDUVIC, M; HELEKAR, B; YOUNG, J et al.Clinical cancer research. 2000, Vol 6, Num 8, pp 3249-3259, issn 1078-0432Article

Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoidsSUN, S.-Y; KURIE, J. M; PING YUE et al.Clinical cancer research. 1999, Vol 5, Num 2, pp 431-437, issn 1078-0432Article